Biosafety and Biosecurity Oversight Should Be a Visible Part of Scientific Rigor

Biomedical research is commonly evaluated by visible outputs such as publications, citations, grants, patents, datasets, clinical applications, and public health benefits. These measures capture important forms of productivity, but they often overlook the biosafety and biosecurity systems that help research proceed safely, responsibly, and credibly. This commentary argues that biosafety and biosecurity oversight should be recognized as a visible component of scientific rigor rather than treated only as background compliance. For research involving biological hazards, emerging biotechnologies, dual-use concerns, or higher containment conditions, safety, and security decisions can shape experimental design, containment strategies, equipment use, material handling, personnel competency, inactivation methods, reproducibility, and interpretation. Much of this risk management occurs after formal approval, during implementation, troubleshooting, training, material transfer, protocol adaptation, and learning from incidents or near misses. Yet current measures of scientific impact rarely recognize this work unless oversight fails. We propose that biosafety and biosecurity be treated as leading indicators of responsible research, supported by risk-based methods statements, recognition of safety expertise as part of team science, and standardized reporting expectations that preserve institutional flexibility. Funders, journals, regulators, and research agencies should make relevant oversight visible without creating unnecessary burden or exposing sensitive security details. Excellent science is not simply the generation of new knowledge. It is the generation of knowledge under conditions that make the work reliable, reproducible, and worthy of public trust.